PL299260A1 - Biphenyl derivatives, therapeutic agents containing them and method of obtaining the sames - Google Patents

Biphenyl derivatives, therapeutic agents containing them and method of obtaining the sames

Info

Publication number
PL299260A1
PL299260A1 PL93299260A PL29926093A PL299260A1 PL 299260 A1 PL299260 A1 PL 299260A1 PL 93299260 A PL93299260 A PL 93299260A PL 29926093 A PL29926093 A PL 29926093A PL 299260 A1 PL299260 A1 PL 299260A1
Authority
PL
Poland
Prior art keywords
sames
obtaining
therapeutic agents
agents containing
biphenyl derivatives
Prior art date
Application number
PL93299260A
Other languages
English (en)
Inventor
Helmut Pieper
Frank Himmelsbach
Guenter Linz
Volkhard Austel
Thomas Mueller
Johannes Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of PL299260A1 publication Critical patent/PL299260A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
PL93299260A 1992-06-11 1993-06-09 Biphenyl derivatives, therapeutic agents containing them and method of obtaining the sames PL299260A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4219158A DE4219158A1 (de) 1992-06-11 1992-06-11 Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
PL299260A1 true PL299260A1 (en) 1994-03-07

Family

ID=6460811

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93299260A PL299260A1 (en) 1992-06-11 1993-06-09 Biphenyl derivatives, therapeutic agents containing them and method of obtaining the sames

Country Status (14)

Country Link
EP (1) EP0574808A1 (xx)
JP (1) JPH0673038A (xx)
KR (1) KR940005554A (xx)
CN (1) CN1080917A (xx)
AU (1) AU4120193A (xx)
CA (1) CA2098158A1 (xx)
DE (1) DE4219158A1 (xx)
FI (1) FI932649A (xx)
HU (1) HU9301700D0 (xx)
IL (1) IL105976A0 (xx)
MX (1) MX9303466A (xx)
NO (1) NO932120L (xx)
PL (1) PL299260A1 (xx)
ZA (1) ZA934090B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406144D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic compounds
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
DK0691959T3 (da) * 1993-03-29 1999-04-26 Zeneca Ltd Heterocykliske derivater som blodpladeaggregations-inhibitorer
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
DE4424974A1 (de) * 1994-07-15 1996-01-18 Thomae Gmbh Dr K Harnstoff- und Carbaminsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19636689A1 (de) 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
UA52797C2 (uk) * 1997-11-20 2003-01-15 Тейдзін Лімітед Похідне біфеніламідину, проліки, інгібітор коагуляції крові, агент для профілактики тромбозу або емболії та агент для терапії тромбозу або емболії
DE19819548A1 (de) * 1998-04-30 1999-11-04 Merck Patent Gmbh Biphenylderivate
AU2868601A (en) * 2000-01-27 2001-08-07 Ribotargets Ltd Biaryl compounds, their preparation and their use in therapy
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
WO2006044975A2 (en) * 2004-10-19 2006-04-27 Compass Pharmaceuticals Llc Compositions and their use as anti-tumor agents
LT3357911T (lt) 2006-06-26 2022-08-10 Akebia Therapeutics Inc. Prolilo hidroksilazės inhibitoriai ir naudojimo būdai
AU2012268400C1 (en) 2011-06-06 2016-12-22 Akebia Therapeutics Inc. Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
NO2686520T3 (xx) 2011-06-06 2018-03-17
CA3151685A1 (en) 2013-06-13 2014-12-18 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
KR102495018B1 (ko) 2013-11-15 2023-02-06 아케비아 테라퓨틱스 인코포레이티드 ｛[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노｝아세트산의 고체형, 이의 조성물 및 용도
WO2016118858A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
SI3277270T1 (sl) 2015-04-01 2022-04-29 Akebia Therapeutics, Inc. Sestavki in postopki za zdravljenje anemije
CA3097219A1 (en) 2018-05-09 2019-11-14 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DK0518819T3 (da) * 1991-06-11 1995-09-25 Ciba Geigy Ag Amidino-forbindelser, deres fremstilling og anvendelse som lægemiddel
DE4127404A1 (de) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL105976A0 (en) 1993-10-20
CN1080917A (zh) 1994-01-19
MX9303466A (es) 1994-01-31
DE4219158A1 (de) 1993-12-16
FI932649A0 (fi) 1993-06-10
NO932120D0 (no) 1993-06-10
KR940005554A (ko) 1994-03-21
ZA934090B (en) 1994-12-11
FI932649A (fi) 1993-12-12
EP0574808A1 (de) 1993-12-22
AU4120193A (en) 1993-12-23
CA2098158A1 (en) 1993-12-12
HU9301700D0 (en) 1993-09-28
NO932120L (no) 1993-12-13
JPH0673038A (ja) 1994-03-15

Similar Documents

Publication Publication Date Title
PL299260A1 (en) Biphenyl derivatives, therapeutic agents containing them and method of obtaining the sames
PL297716A1 (en) Benzimidazolyl derivatives, method of obtaining them and therapeutic agents containing such compounds
PL305543A1 (en) Derivatives of 1-amino ethylindole, method of obtaining them and therapeutic agents containming such derivatives
PL300673A1 (en) Derivatives of carboxylic acids, therapeutic agents containing them and method of obtaining sames
PL300347A1 (en) Cyclic urea derivatives, therapeutic agents containing them and method of obtaining sames
PL300628A1 (en) Qinolonocarboxylic acids, method of obtaining sames and medicines/microbicides containing them
GB9203790D0 (en) Therapeutic agents
PL299754A1 (en) Benzimidazoles, therapeutic agent containing them and method of obtaining the sames
PL298449A1 (en) Novel benzimidazoles, method of obtaining sames and therapeutic agents containing them
GB2267089B (en) Cycloheptimidazole derivatives,method of manufacturing the same and therapeutic agents containing these compounds
GB8629568D0 (en) Therapeutic agent
PL300585A1 (en) Benzimidazoles, therapeutic agents containing them and method of obtaining sames
ZA932553B (en) New use of B-carbolines
PL297561A1 (en) Novel 4-cinoline- and 4-naphtiridine-dihydropyridines, method of obtaining sames and their applications as therapeutic agents
PL311467A1 (en) Substituted benzoyloguanidines, method of obtaining them and therapeutic agent containing such compounds
GB9200781D0 (en) Therapeutic agents
GB2280438B (en) Carboxymethylidenecycloheptimidazole derivatives,method of manufacturing the same and therapeutic agents containing these compounds
PL297872A1 (en) Substituted sulfonylbenzyloimidazopyridines, method of obtaining them and drugs containing them
PL306244A1 (en) Oxazolydin-2-one derivatives, method of obtaining them and therapeutic agents containing such derivatives
PL304774A1 (en) Pename derivatives, method of obtaining them and therapeutic agents containing such derivatives
PL301024A1 (en) Cephalosporine derivatives, method of obtaining same and therapeutic agents containing them
GB9203348D0 (en) New use of wf13533 substance
GB8529885D0 (en) Therapeutic agent
PL307630A1 (en) Beta-lactames, method of obtaining them and therapeutic agents containing such compounds
GB9215226D0 (en) New therapeutic method